Edition:
United Kingdom

Histogenics Corp (HSGX.OQ)

HSGX.OQ on NASDAQ Stock Exchange Capital Market

2.37USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,842
52-wk High
$3.26
52-wk Low
$1.61

Chart for

About

Histogenics Corporation is a regenerative medicine company. The Company is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The Company's product candidate, NeoCart utilizes various aspects of regenerative medicine platform to develop a tissue implant intended to treat tissue... (more)

Overall

Beta: --
Market Cap(Mil.): $49.25
Shares Outstanding(Mil.): 22.49
Dividend: --
Yield (%): --

Financials

  HSGX.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.65 -- --
ROI: -84.46 15.07 14.61
ROE: -168.38 16.60 16.34

BRIEF-Perceptive Advisors LLC Reports 8.8 pct Passive Stake In Histogenics As Of Jan. 17

* PERCEPTIVE ADVISORS LLC REPORTS 8.8 PERCENT PASSIVE STAKE IN HISTOGENICS CORP AS OF JANUARY 17, 2018 - SEC FILING‍​ Source text - (http://bit.ly/2GlVfLJ) Further company coverage:

26 Jan 2018

Earnings vs. Estimates